cGAS-STING pathway regulated by spatiotemporal heterogeneity of tumor microenvironment and precision therapy

Jing-Ying Ye1, Ying Pan2, Miao Li1

  • 1Department of Clinical Pharmacology, School of Pharmacy, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning, 110122, China.

Insights

The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway has a dual role in lung cancer, impacting immunity and metastasis. Understanding its interaction with the tumor microenvironment (TME) is key for new treatments.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • The cGAS-STING pathway is crucial for innate immunity.
  • It plays a complex, dual role in lung cancer, influencing both anti-tumor immunity and immune escape.
  • Tumor microenvironment (TME) heterogeneity significantly impacts cGAS-STING pathway activity.

Purpose of the Study:

  • To systematically review the pro- and anti-tumorigenic roles of the cGAS-STING pathway in lung cancer.
  • To explore how TME spatiotemporal heterogeneity modulates cGAS-STING pathway activity.
  • To discuss cGAS-STING-driven precision immunotherapy and AI optimization strategies.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of the interplay between TME components (cell types, physicochemical gradients) and cGAS-STING signaling.
  • Integration of immunometabolism and TME heterogeneity concepts.

Main Results:

  • The cGAS-STING pathway's function is context-dependent within the heterogeneous TME.
  • Spatiotemporal variations in the TME dynamically alter cGAS-STING pathway activity.
  • Immunometabolism and TME heterogeneity are critical factors influencing cGAS-STING pathway outcomes.

Conclusions:

  • Understanding the dynamic interplay between TME heterogeneity and the cGAS-STING pathway is essential for developing effective lung cancer therapies.
  • Targeting the cGAS-STING pathway, considering TME context, offers potential for novel immunotherapies.
  • Integrating these factors may improve treatment strategies, overcome resistance, and enhance patient survival.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...